Dr Chris Hardy appointed as Alzheimer’s Society Carol Jennings Fellow
Alzheimer's SocietyAlzheimer’s Society has announced that Dr Chris Hardy from University College London is to become their second Carol Jennings Research Fellow
Research News
SHIMMER Trial Reports Positive Results
Dementia ResearcherExciting results from Cognition Therapeutics’ Phase 2 SHIMMER study of CT1812 for DLB: met safety endpoints & improved cognitive & motor functions. Details coming at January’s LBD Conference
Learning from the ‘Crossing the line’ Project
Explore key insights from University of Worcester’s 18-month study on family carers of dementia patients. Discover our new educational resources to aid care.
PPI with policymakers & practitioners: NIHR Active-6 study
NIHRNIHR Webinar series, drawing on the experiences of public contributors and researchers, will showcase examples of patient and public involvement in research.
New UK-Swiss bilateral funding for clinical trials to open in 2025
New NIHR £8m funding will soon be available for joint Swiss-UK clinical trials and to support early-career research capacity strengthening.
South West Dementia Brain Bank 40th Anniversary
Celebrating 40 years the SW Dementia Brain Bank shares its journey, achievements, and future impact. Watch the talks from Prof Patrick Kehoe & Dr Laura Palmer
Inclusion now a key condition for NIHR funding
The NIHR now requires applicants to show how their research tackles health & care inequalities. Learn about this key funding change
Care home app reduced residents’ hospital admissions
NIHR Evidence has published new work showing the HealthCall Digital Care Homes app cuts hospital admissions by 25% & stays by 11%, saving £113/resident annually
Springer Healthcare news from the CTAD Conference
Springer Healthcare were at the CTAD Conference earlier this month. Check out this post for news from the event and updates on anti-amyloid treatments
SPIN-D: Building Connections for Inclusive Dementia Care
Watch the launch of the SPIN-D network +. Exploring community engagement and innovative approaches to support inclusive, person-centred dementia care.
Exploring New Social Horizons: X-odus to BlueSky Social
Explore why dementia researchers are joining Bluesky—a values-driven, customisable social media space. Follow us for updates @dementiaresearcher.bsky.social
European Medicines Agency changes opinion on Lecanemab
Following a re-examination of its initial opinion, EMA issues a positive opinion on authorisation of Lecanemab / Leqembi for the treatment of early Alzheimer’s